Follow us on WhtasApp Channel
Wednesday, December 25, 2024
Follow us on Whatsapp Channel

Latest News

Industry

CDSCO directs expedited Approval of Rare Disease Drugs and Medical Devices

The Health Master The Health Master -
Medical Education / Hospital / Doctors

CDSCO approves Robotic System for Telesurgery

The Health Master The Health Master -
States

MN Sridhar has been appointed as Director of Drug Control Administration: Tamil Nadu

The Health Master The Health Master -
Nation

NPPA approves price increase for 11 Drugs

The Health Master The Health Master -
Industry

Four arrested for supplying Spurious Drugs to Maharashtra Hospital

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene

Rakesh Dahiya Rakesh Dahiya -
Industry

Wearable Medical device: The Future of Heart Health Monitoring

The Health Master The Health Master -
Industry

Blast at Hyderabad pharma unit: NGT issues notice

The Health Master The Health Master -
- Advertisement -
Nation

Piramal Pharma Pays USD 407,400 to Resolve Legal Battle

The Health Master The Health Master -
Industry

India Boosts Pharma Manufacturing with Rs 15,000 Crore PLI Scheme

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 3 – Good Manufacturing Practice (GMP)

Rakesh Dahiya Rakesh Dahiya -
Industry

AIDCOC Seeks Revocation and Investigation on Karnataka Drug Controller Suspension

The Health Master The Health Master -
Industry

Himachal Pradesh cracks down on NSQ Drugs Manufacturers

The Health Master The Health Master -
Industry

USFDA approval granted for Latanoprost Ophthalmic Solution

The Health Master The Health Master -
Industry

DCOIWA appeals for reinstatement of State Drugs Controller Karnataka

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 2 – Quality Risk Management

Rakesh Dahiya Rakesh Dahiya -
- Advertisement -
Govt Job Alert

How to become a Pharmacist in America ?

The Health Master The Health Master -
Medical Education / Hospital / Doctors

DCA Telangana crackdown on illegal Medical Practices

The Health Master The Health Master -
Industry

Drug alert: 3,270 samples declared as NSQ in 2023-24

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Point No. 1 – Pharmaceutical Quality System

Rakesh Dahiya Rakesh Dahiya -
Industry

USFDA issues OAI Classification after inspection to Granules India

The Health Master The Health Master -
Industry

MSMEs Commit to Revised Schedule M for Drug Quality

The Health Master The Health Master -
Articles -Pharma & Cosmetics

Key Notes on Revised Schedule M: Compilation

Rakesh Dahiya Rakesh Dahiya -
Industry

CDSCO Panel approval granted for Anti Cancer Drug Pertuzumab

The Health Master The Health Master -
- Advertisement -
1234...382Page 3 of 382

Industry News

NPPA fixed retail price of 7 formulations: December 2024

IndustryThe Health MasterThe Health Master -

Revised Schedule M: Industry seeks balance between Quality and Viability

IndustryThe Health MasterThe Health Master -

FDA Karnataka enters a New Era of Food and Drug Safety

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 13 – Equipment

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

GST Penalty of Rs. 1.11 Crore on Cipla

IndustryThe Health MasterThe Health Master -

FSSAI regulations on use of Methylcobalamin in Supplements

Health and FitnessThe Health MasterThe Health Master -

FOPE demands inclusion of Sensitive drugs in Schedule P

IndustryThe Health MasterThe Health Master -

Parliamentary Panel demands swift action on Spurious Drugs

IndustryThe Health MasterThe Health Master -

Forms: For Homoeopathy Medicines

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 12 – Premises

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Indian Pharma Market growth: To Reach Rs 2.38 Lakh Crore by 2025

IndustryThe Health MasterThe Health Master -

Over the Counter (OTC) Drug Revolution: New List Coming Soon

IndustryThe Health MasterThe Health Master -

NPPA revised Ceiling price of 13 scheduled formulations: December 2024

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 11 – Personnel

IndustryRakesh DahiyaRakesh Dahiya -

USFDA issued Form 483 with two observations to Aurobindo for API plant

IndustryThe Health MasterThe Health Master -

NPPA fixed retail price of 65 formulations: December 2024

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 10 – Self Inspection

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Medical Device recall: USFDA classifies recall of these catheters as ‘most serious’

IndustryThe Health MasterThe Health Master -

NPPA: New Strategy to Curb Drug Price Hikes

NationThe Health MasterThe Health Master -

Pharmexcil 2024 Elections: New Leadership for India’s Pharmaceutical Industry

NationThe Health MasterThe Health Master -

Drug recall: 1,394 batches of drugs recalled in 2023-24 due to quality issues

NationThe Health MasterThe Health Master -

Chemists want Ayurvedic Medicine Under FDA Scrutiny

IndustryThe Health MasterThe Health Master -

USFDA issues warning letter to Indoco Remedies for Goa facility

IndustryThe Health MasterThe Health Master -

Karnataka creates unified Food and Drug Administration (FDA)

IndustryThe Health MasterThe Health Master -

CDSCO to undergo massive Expansion in the coming year

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 9 – Production under Loan License

IndustryRakesh DahiyaRakesh Dahiya -

Action against sale of habit-forming drugs without prescription: Tamil Nadu

IndustryThe Health MasterThe Health Master -

Gujarat’s Medical Device Park: A Game-Changer for India’s Healthcare Sector

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 8 – Change Control

IndustryRakesh DahiyaRakesh Dahiya -

Drug recall: Aurobindo Pharma, Glenmark, Zydus recall Drugs

IndustryThe Health MasterThe Health Master -

USFDA approval granted for this Genetic Disorder drug

IndustryThe Health MasterThe Health Master -

Aurobindo Pharma Faces Rs 11 Crore GST Demand

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 7 – Product Recall

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Double Approval: New Pneumonia Drugs Get CDSCO and USFDA Nod

IndustryThe Health MasterThe Health Master -

Govt Expands Medical Device Testing Laboratories

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 6 – Complaints and Adverse reaction

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

NABL reforms Accreditation Processes to boost Testing Laboratories

NationThe Health MasterThe Health Master -

Ayush Ministry Amends D&C Act: A Boon for Homoeopathy

IndustryThe Health MasterThe Health Master -

Brazilian Regulators successfully completes GMP Audit of Alembic Pharma

IndustryThe Health MasterThe Health Master -

CDSCO approval granted to market Insulin Inhalation Powder

IndustryThe Health MasterThe Health Master -

DCGI to inaugurate AIPAC Event: A Boon for Indian Pharmaceutical

NationThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

CDSCO directs expedited Approval of Rare Disease Drugs and Medical Devices

IndustryThe Health MasterThe Health Master -

CDSCO approves Robotic System for Telesurgery

Medical Education / Hospital / DoctorsThe Health MasterThe Health Master -

MN Sridhar has been appointed as Director of Drug Control Administration: Tamil Nadu

StatesThe Health MasterThe Health Master -

NPPA approves price increase for 11 Drugs

NationThe Health MasterThe Health Master -

Four arrested for supplying Spurious Drugs to Maharashtra Hospital

IndustryThe Health MasterThe Health Master -

Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Wearable Medical device: The Future of Heart Health Monitoring

IndustryThe Health MasterThe Health Master -

Blast at Hyderabad pharma unit: NGT issues notice

IndustryThe Health MasterThe Health Master -

Piramal Pharma Pays USD 407,400 to Resolve Legal Battle

NationThe Health MasterThe Health Master -
Load more

Authors

Rakesh Dahiya
Rakesh Dahiya
138 POSTS0 COMMENTS
Lalit Kr. Goel
Lalit Kr. Goel
40 POSTS0 COMMENTS
Nidhi Gudwani
Nidhi Gudwani
40 POSTS0 COMMENTS
N K Ahooja
N K Ahooja
20 POSTS0 COMMENTS
Dr. Kumud Madan
Dr. Kumud Madan
13 POSTS0 COMMENTS
Dipika Chauhan
Dipika Chauhan
13 POSTS0 COMMENTS
Naripen Goyal
Naripen Goyal
11 POSTS0 COMMENTS
Sushant Mahapatra
Sushant Mahapatra
9 POSTS0 COMMENTS
Dr. Bharatesh R Jagashetty
Dr. Bharatesh R Jagashetty
7 POSTS0 COMMENTS
Dr. B Suresh
Dr. B Suresh
5 POSTS0 COMMENTS
Manmohan Taneja
Manmohan Taneja
5 POSTS0 COMMENTS
Dr. J K Jha
Dr. J K Jha
5 POSTS0 COMMENTS
Dr. BN Nagpal
Dr. BN Nagpal
4 POSTS0 COMMENTS
Dr. Brahmdeep Sindhu
Dr. Brahmdeep Sindhu
4 POSTS0 COMMENTS
H. Mahapatra
H. Mahapatra
3 POSTS0 COMMENTS
Nilesh Gandhi
Nilesh Gandhi
3 POSTS0 COMMENTS
http://www.pharmastute.com
Dr. P K Sreekumar
Dr. P K Sreekumar
2 POSTS0 COMMENTS
Dr. NPS Verma
Dr. NPS Verma
2 POSTS0 COMMENTS
Sanjay Malhotra
Sanjay Malhotra
1 POSTS0 COMMENTS
http://www.aerolgroup.com
P P Sharma
P P Sharma
1 POSTS0 COMMENTS
Dr. Balraj Yadav
Dr. Balraj Yadav
1 POSTS0 COMMENTS
Dr. Gulshan Rai Arora
Dr. Gulshan Rai Arora
1 POSTS0 COMMENTS
Prof Vivek Padgaonkar
Prof Vivek Padgaonkar
1 POSTS0 COMMENTS
https://www.linkedin.com/in/vivek-padgaonkar-8298509/
Adarsh Goyal
Adarsh Goyal
1 POSTS0 COMMENTS
K C Aggarwal
K C Aggarwal
1 POSTS0 COMMENTS
P K Jaggi
P K Jaggi
1 POSTS0 COMMENTS

Articles; Pharma, Cosmetics, Medical Devices

Key Notes on Revised Schedule M: Point No. 13 – Equipment

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Forms: For Homoeopathy Medicines

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 12 – Premises

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 11 – Personnel

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 10 – Self Inspection

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 9 – Production under Loan License

IndustryRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 8 – Change Control

IndustryRakesh DahiyaRakesh Dahiya -

Forms: All types for Hospital RMI

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 7 – Product Recall

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 6 – Complaints and Adverse reaction

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 5 – Qualification and validation

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 4 – Sanitation and Hygiene

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 3 – Good Manufacturing Practice (GMP)

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 2 – Quality Risk Management

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Point No. 1 – Pharmaceutical Quality System

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Notes on Revised Schedule M: Compilation

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Key Changes for Homoeopathic Medicines: GSR 669(E) dated 28-10-2024

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

FSSAI: Food Labelling and Display – Chapter-12

Articles -Pharma & CosmeticsDipika ChauhanDipika Chauhan -

Significance of Granules Manufacturing in the Pharmaceutical Industry

Articles -Pharma & CosmeticsRakesh DahiyaRakesh Dahiya -

Important short notes for Industry and Regulators

Articles -Pharma & CosmeticsLalit Kr. GoelLalit Kr. Goel -

FSSAI: Food Labelling and Display – Chapter-11

Articles -Pharma & CosmeticsDipika ChauhanDipika Chauhan -

FSSAI: Food Labelling and Display – Chapter-10

IndustryDipika ChauhanDipika Chauhan -

Key components of Uniform Code for Marketing Practices in Medical Devices (UCMPMD) 2024

Articles -Pharma & CosmeticsDr. BN NagpalDr. BN Nagpal -

FSSAI: Food Labelling and Display – Chapter-9

IndustryDipika ChauhanDipika Chauhan -
Load more

World

Load more

Nation

Load more

State

Load more

Pharmacy Education / Medical Store

Load more

Medical Education / Hospital / Doctors

View All

Govt Job Alert

Load more
spot_img

Health & Fitness

View All

FSSAI regulations on use of Methylcobalamin in Supplements

The Health Master The Health Master -
Methylcobalamin The Food Safety and Standards Authority of India...

Naloxone: The Lifesaver You Need to Know About

The Health Master The Health Master -
Naloxone Opioid overdoses are a tragic reality, but they don't...

Chemists demand reversal of Door Step Delivery Order

The Health Master The Health Master -
Door Step Delivery Download the notification G.S.R. 220 (E) dated...

Over the Counter (OTC) Drug Revolution: New List Coming Soon

The Health Master The Health Master -
OTC India is poised to revolutionize its pharmaceutical landscape with...
Load more

Articles: Legal

Load more

EDITOR PICKS

Load more

POPULAR POSTS

Load more

POPULAR CATEGORY

ABOUT US

Perfect platform for latest consolidated news, articles, information in the healthcare, medical and pharmaceuticals sectors, including Medical News, Pharmaceutical News, Pharmacy education news, Medical Education news, and many more

Contact us: thehealthmaster19@gmail.com

FOLLOW US

© 2019 - 2024 Website Designed & Managed by The Health Master